Page last updated: 2024-09-03

neo-gambogic acid and Colorectal Neoplasms

neo-gambogic acid has been researched along with Colorectal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Gong, Y; Gu, Y; Li, Y; Lu, Y; Wang, H; Wu, M1
Bi, Y; Guo, J; Liu, Y; Pan, L; Tan, Y; Yu, X; Zhao, Q; Zhong, J1

Other Studies

2 other study(ies) available for neo-gambogic acid and Colorectal Neoplasms

ArticleYear
Neogambogic acid suppresses characteristics and growth of colorectal cancer stem cells by inhibition of DLK1 and Wnt/β-catenin pathway.
    European journal of pharmacology, 2022, Aug-15, Volume: 929

    Topics: Apoptosis; beta Catenin; Calcium-Binding Proteins; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Glycogen Synthase Kinase 3 beta; Humans; Membrane Proteins; Neoplastic Stem Cells; Proliferating Cell Nuclear Antigen; Wnt Signaling Pathway; Xanthenes

2022
Gambogenic acid induces Noxa-mediated apoptosis in colorectal cancer through ROS-dependent activation of IRE1α/JNK.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2020, Volume: 78

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Endoplasmic Reticulum Stress; Endoribonucleases; Female; Humans; JNK Mitogen-Activated Protein Kinases; Mice, Inbred BALB C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Xanthenes; Xenograft Model Antitumor Assays

2020